{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

NASDAQ: TRAW

Traws Pharma, Inc.

CIK 0001130598 · Pharmaceutical Preparations

8-K Filed May 27, 2026 · Period ending May 27, 2026

Traws Pharma launches antiviral program targeting Hantavirus and Ebola outbreaks

2 material changes detected. Sign up free to read the summary.

View report
8-K Filed May 26, 2026 · Period ending May 22, 2026

Traws Pharma updates ATM offering limit to $3.1M under baby shelf rules

3 material changes detected. Sign up free to read the summary.

View report

Partner

Trade TRAW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed May 15, 2026 · Period ending Mar 31, 2026 Risk improved

Traws remedies control weaknesses, raises $10M as FDA halts lead drug; cash at $3.1M

5 material changes detected. Sign up free to read the summary.

View report
8-K Filed May 15, 2026 · Period ending May 15, 2026

Traws Pharma reports Q1 2026 financial results in Regulation FD disclosure

2 material changes detected. Sign up free to read the summary.

View report
10-K Filed Apr 15, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 13, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed May 15, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Mar 31, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

View all filings for TRAW on SEC EDGAR